GAM
Grandview Asset Management’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-9,144
| Closed | -$232K | – | 137 |
|
2025
Q1 | $232K | Buy |
9,144
+113
| +1% | +$2.87K | 0.09% | 117 |
|
2024
Q4 | $240K | Buy |
+9,031
| New | +$240K | 0.09% | 110 |
|
2024
Q2 | – | Sell |
-10,054
| Closed | -$279K | – | 88 |
|
2024
Q1 | $279K | Buy |
10,054
+145
| +1% | +$4.02K | 0.13% | 95 |
|
2023
Q4 | $285K | Sell |
9,909
-46
| -0.5% | -$1.32K | 0.15% | 89 |
|
2023
Q3 | $330K | Buy |
+9,955
| New | +$330K | 0.19% | 81 |
|
2023
Q2 | – | Sell |
-10,304
| Closed | -$420K | – | 96 |
|
2023
Q1 | $420K | Buy |
10,304
+81
| +0.8% | +$3.3K | 0.25% | 76 |
|
2022
Q4 | $524K | Sell |
10,223
-1,003
| -9% | -$51.4K | 0.33% | 66 |
|
2022
Q3 | $491K | Sell |
11,226
-916
| -8% | -$40.1K | 0.31% | 67 |
|
2022
Q2 | $637K | Sell |
12,142
-3,055
| -20% | -$160K | 0.36% | 63 |
|
2022
Q1 | $787K | Buy |
15,197
+1,826
| +14% | +$94.6K | 0.33% | 63 |
|
2021
Q4 | $790K | Buy |
+13,371
| New | +$790K | 0.32% | 68 |
|
2021
Q3 | – | Sell |
-5,211
| Closed | -$204K | – | 100 |
|
2021
Q2 | $204K | Buy |
5,211
+728
| +16% | +$28.5K | 0.11% | 102 |
|
2021
Q1 | $162K | Buy |
+4,483
| New | +$162K | 0.09% | 133 |
|
2020
Q1 | – | Sell |
-11,940
| Closed | -$467K | – | 61 |
|
2019
Q4 | $467K | Sell |
11,940
-616
| -5% | -$24.1K | 0.44% | 51 |
|
2019
Q3 | $445K | Sell |
12,556
-93
| -0.7% | -$3.3K | 0.4% | 59 |
|
2019
Q2 | $548K | Sell |
12,649
-924
| -7% | -$40K | 0.51% | 52 |
|
2019
Q1 | $576K | Buy |
13,573
+116
| +0.9% | +$4.92K | 0.53% | 54 |
|
2018
Q4 | $587K | Buy |
+13,457
| New | +$587K | 0.62% | 47 |
|